Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersDermatology Physician in Washington, DC
NPI: 1558547349Primary Practice Location
HOWARD UNIVERSITY HOSPITAL CORP
2041 Georgia Ave Nw, Washington, DC
Primary Employer
Faculty Practice Plan Howard University
hufpp.com
HQ Phone
Get M.D. Ginette's Phone Numberphone_androidMobile
Get M.D. Ginette's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardDC State Medical License
MD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 19 | 36 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 15 | 15 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 12 | 22 |
Thalidomide for the treatment of chronic refractory prurigo nodularis.
Authors: Aguh, Crystal, Kwatra, Shawn G, He, Alice, Okoye, Ginette A
Journal: Dermatol Online J
Publication Date: 2018-03-15
Authors: Nancy Maly, Anna Chien, Luke Wallis
Journal: JAMA Dermatol
Authors: Seemal Desai, Candrice Heath, Lynn Mckinley-Grant, Valerie Callender, Valerie Harvey, Stafford Brown, Adewole Adamson
Journal: JAMA Dermatol
Lead Sponsor: Johns Hopkins University
Intervention / Treatment: DEVICE: Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet
Lead Sponsor: University of Pennsylvania
Collaborators: Patient-Centered Outcomes Research Institute, University of Utah, National Psoriasis Foundation
Intervention / Treatment: DEVICE: Daavlin 7 series 3 panel narrow band phototherapy home units, DEVICE: narrow band phototherapy clinic units
Lead Sponsor: Eli Lilly and Company
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Baricitinib
